Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Mar 19;330(7492):625.
doi: 10.1136/bmj.330.7492.625.

How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review

Jenny A Doust  1 , Eva Pietrzak, Annette Dobson, Paul Glasziou
Affiliations

How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review

Jenny A Doust et al. BMJ. .

Abstract

Objective: To assess how well B-type natriuretic peptide (BNP) predicts prognosis in patients with heart failure.

Design: Systematic review of studies assessing BNP for prognosis in patients with heart failure or asymptomatic patients.

Data sources: Electronic searches of Medline and Embase from January 1994 to March 2004 and reference lists of included studies.

Study selection and data extraction: We included all studies that estimated the relation between BNP measurement and the risk of death, cardiac death, sudden death, or cardiovascular event in patients with heart failure or asymptomatic patients, including initial values and changes in values in response to treatment. Multivariable models that included both BNP and left ventricular ejection fraction as predictors were used to compare the prognostic value of each variable. Two reviewers independently selected studies and extracted data.

Data synthesis: 19 studies used BNP to estimate the relative risk of death or cardiovascular events in heart failure patients and five studies in asymptomatic patients. In heart failure patients, each 100 pg/ml increase was associated with a 35% increase in the relative risk of death. BNP was used in 35 multivariable models of prognosis. In nine of the models, it was the only variable to reach significance-that is, other variables contained no prognostic information beyond that of BNP. Even allowing for the scale of the variables, it seems to be a strong indicator of risk.

Conclusion: Although systematic reviews of prognostic studies have inherent difficulties, including the possibility of publication bias, the results of the studies in this review show that BNP is a strong prognostic indicator for both asymptomatic patients and for patients with heart failure at all stages of disease.

PubMed Disclaimer

Comment in

References

    1. Bouvy ML, Heerdink ER, Leufkens HG, Hoes AW. Predicting mortality in patients with heart failure: a pragmatic approach. Heart 2003;89: 605-9. - PMC - PubMed
    1. Cowie MR, Wood DA, Coats AJ, Thompson SG, Suresh V, Poole-Wilson PA, et al. Survival of patients with a new diagnosis of heart failure: a population based study. Heart 2000;83: 505-10. - PMC - PubMed
    1. Scrutinio D, Lagioia R, Ricci A, Clemente M, Boni L, Rizzon P. Prediction of mortality in mild to moderately symptomatic patients with left ventricular dysfunction. The role of the New York Heart Association classification, cardiopulmonary exercise testing, two-dimensional echocardiography and Holter monitoring. Eur Heart J 1994;15: 1089-95. - PubMed
    1. Aaronson KD, Schwartz JS, Chen TM, Wong KL, Goin JE, Mancini DM. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 1997;95: 2660-7. - PubMed
    1. Doust JA, Glasziou PP, Pietrzak E, Dobson AJ. A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure. Arch Intern Med 2004;164: 1978-84. - PubMed

Publication types